B&G Partners LLC
Records under this name other than the patents B&G Partners LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 8 of 8 · Back to B&G Partners LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,821,974 | Stable pharmaceutical compositions Term ended Term ended Mar 5, 2022 · From the USPTO record | Term ended | Term ended Mar 5, 2022 | From the USPTO record |
| US 8,871,744 | Compounds and methods for selectively targeting tumor-associated mucins Lapsed on the fee record Ended Oct 28, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2018 | From the USPTO record |
| US 7,119,079 | Bioadhesive pharmaceutical compositions Lapsed on the fee record Ended Oct 10, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 10, 2018 | From the USPTO record |
| US 8,778,892 | Compounds and methods for treatment of solid tumors Lapsed on the fee record Ended Jul 15, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 15, 2018 | From the USPTO record |
| US 7,728,133 | Stable pharmaceutical compositions Lapsed on the fee record Ended Jun 1, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jun 1, 2018 | From the USPTO record |
| US 6,699,848 | Bioadhesive anti-inflammatory pharmaceutical compositions Lapsed on the fee record Ended Mar 2, 2016 · From the USPTO record | Lapsed on the fee record | Ended Mar 2, 2016 | From the USPTO record |
| US 8,088,918 | Noncardiotoxic pharmaceutical compounds Lapsed on the fee record Ended Jan 3, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jan 3, 2016 | From the USPTO record |
| US 7,358,271 | Sulpiride pharmaceutical compositions Lapsed on the fee record Ended Apr 15, 2012 · From the USPTO record | Lapsed on the fee record | Ended Apr 15, 2012 | From the USPTO record |